Meeting of Board of Directors is held today for approval Unaudited Financial Results for the half year ended on 30.09.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novateor Research Laboratories' Board approved unaudited standalone results for the half year ended September 30, 2025. Revenue from operations jumped sharply to Rs. 247.00 lakhs from Rs. 79.32 lakhs in the same period last year, a jump of over 200%, though the company slipped into a small loss of Rs. 1.59 lakhs versus a profit of Rs. 3.32 lakhs previously. EPS turned slightly negative at Rs. (0.01). The auditor issued a Qualified Conclusion flagging non-compliance with AS-2 (inventory valuation), AS-15 (gratuity not provided), and AS-17 (no segment reporting), and added an Emphasis of Matter on the revaluation of long-lease land. Operating cash flow remained deeply negative at Rs. (78.43) lakhs, while share capital rose to Rs. 605.22 lakhs from Rs. 483.42 lakhs on conversion of warrants.
Strong top-line growth is a positive signal, but the swing to a loss, weak cash generation, and a qualified audit opinion with multiple accounting deviations raise concerns about earnings quality and may keep the stock under pressure despite the revenue momentum.